|
|
|
|
|
Kyowa Hakko Kogyo Co.
|
|
Kyowa Hakko Kogyo Co having its headquarters in Tokyo, Japan is considered to be one of the most reputed and renowned inventor, producer and marketer of pharmaceutical and biotechnological products since more than five decades now. The company is leading in the advancement and application of fermentation technology as well as innovative kinds of biotechnology. The company’s key pharmaceutical research has been targeted on the drug discovery through support of antibody techniques and developing therapeutic agents for cancer and allergic disorders.
Kyowa Hakko has obtained universal triumph with a couple of agents such as: Mitomycin which is designated for adenocarcinoma of the stomach and the pancreas and is being sold in the United State markets through Bristol-Myers Squibb under the brand name as Mutamycin. The other agent is Olopatadine which is meant to ease itching of the eyes caused because of allergic conjunctivitis and sold in the United States through Alcon under the brand called Patanol.
Basically the company is actively manufacturing pharmaceuticals and chemicals and its operations are managed through different divisions such as: Pharmaceuticals, Bio-chemicals, Chemicals, Foods and others. Pharmaceuticals incorporate ethical drugs, bulk drugs and biological research. Bio-chemicals division handles the bio-chemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemical division incorporates solvents, plasticizes and its raw materials detergent raw materials and specialty chemicals. Food division covers alcoholic beverages, alcohol, seasonings, confectionery, baking materials and processed foods while others take care of distribution of wholesale commodity and installation facilities.
The company is immensely acknowledged for providing many therapeutic drugs like: Coniel – for treating hypertension and angina pectoris, Neu-up for treating Neutropenia and anti-allergic drug called Allelock.
|
|
|
|
|
|
|
Whyeth
, Elcon
, Bosch and Lomb
, Solvey
, Forast Laboratories
, Dr Redys Laboratories Ltd
,
, Hofmann_La Roche
, Bristal_Myers Squibb
, Merk and Co
|
|
|
|
|
| Latest News About kyowa hakko kogyo co. |
|
|
|
No liability can suppose, what supposed also always for actions any information been based, that subsequently may prove to be incorrect. Kyowa Hakko Kogyo Co., Ltd. ....More |
|
|
|
|
Firm research at vacuum cleaners: : Kyowa Hakko Kogyo firm Ltd. Show more... ABIX over COMTEX) -- Kyowa Hakko Kogyo revenue is learned diminished for its alcohol....More |
|
|
|
|
On the 10 June, 2002 Kyowa Hakko Kogyo Co.,, Ltd began. a phase I early Phasenii. Study of KW-2871 (code number) for the treatment of vicious melanoma in....More |
|
|
|
|
Kyowa Hakko Kogyo Co., is Ltd. a research oriented firm, that will be dedicated concentrated on biotechnology and, to. the creation of new value in the life sciences,....More |
|
|
|
|
Kyowa Hakko Kogyo Co., is Ltd. a firm been based on RandD, that is dedicated to the creation of new value in life. Sciences, especially in its two core business....More |
|
|
|
|
Downward pressure on salaries of grim competition for head drug, prices cut, and growing RandD costs. A well developed product piping in spite of its....More |
|
|
|
|
In return Kyowa Hakko Kogyo Co. an option has to develop and will be responsible to commercialize the product in Asia, and for all development activities and....More |
|
|
|
|
TOKYO, on the 23 August, Kyodo JBN-AsiaNet - Kyowa Hakko Kogyo Co., gmbh (president and... KYOWA HAKKO KOGYO CO., LTD. 1-6-1 of the Ohtemachi, Chiyoda-ku Tokyo 100-8185....More |
|
|
|
|
Andquot; it was long is my dream to run a Kyowa Hakko Kogyo firm into the countries, andquot; it says. Mr. Fujiwara has previously as a general director of Kyowaand gedient...More |
|
|
|
|
Kyowa Hakko Kogyo Co. Ltd. (Japan).. Also in 1991, Co. a new subsidiary has called arranged Kyowa Hakko AND K. Co. Ltd. in. London. ....More |
|
|
|
|
|
|
|